Michaelides M

Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse, Baltimore, Maryland. Electronic address: Mike.michaelides@nih.gov.

3 papers · ORCID

ArticleKetamine

Bifunctional Modulation of NMDA and Opioid Receptors in Ketamine Reinforcement and Misuse: Implications for Substance Use Disorder Treatment.

Levinstein MR, Schoenborn I, Manza P +4

Europe PMC2026
ArticleKetamine

The dopaminergic effects of esketamine are mediated by a dual mechanism involving glutamate and opioid receptors.

Rizzo A, Garçon-Poca MZ, Essmann A +4

Europe PMC2025
ArticleKetamine

Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?

Levinstein MR, Budinich RC, Bonaventura J +3

Europe PMC2025